Skip to content

A study on using Polyethylene glycol and Bisacodyl to relieve constipation in people with advanced cancer receiving palliative care.

Prospective observational single arm study evaluating Polyethylene glycol plus Bisacodyl for managing constipation in patients with advanced cancers under specialist palliative care - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086361
Enrollment
280
Registered
2025-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18 years or more and willing to participate 2.Referred to Department of Palliative Medicine with constipation more than or equal to 3 out of 10 in numerical rating score NOT on T Bisacodyl 5mg tablet + syrup PEG 20ml in 200ml water. 3.Able to communicate and understand English/Hindi/Marathi 4.Able to give written informed consent for questionnaire administration 5.Diagnosed case of advanced malignancy

Exclusion criteria

Exclusion criteria: 1.Unstable medical condition requiring emergency treatment 2.Pre-existing Psychiatric disorder or cognitive impairment preventing patients from comprehending questionnaire 3.Known or suspected bowel obstruction or ileus 4.Presence of a colostomy or ileostomy 5.History of inflammatory bowel disease 6.Colorectal Primary Site of Cancer 7.Contraindication to any of the medication used Eg.Patients on Parenteral Hydration and nutrition only

Design outcomes

Primary

MeasureTime frame
Frequency as percentage of responders (Responders will be defined as having passed any bowel movement in 48 hours following initiation of laxative) Timepoint: Baseline and 48 hours

Secondary

MeasureTime frame
1)To evaluate change in numerical rating score for constipation in Edmonton Symptom Assessment System- Revised CS at 48 hours after initiation of laxative 2) To evaluate patient reported adverse effects at 48 hours a) As reported by patients b) In Edmonton Symptom Assessment System- Revised CS: Other Problem row; with a numerical rating score 0 to 10 3) To understand the factors associated with effectiveness of laxative and contributing factors in non-responders 4) To understand the compliance to prescribed laxatives as per standard OPD practice Timepoint: Baseline and 48 hours

Countries

India

Contacts

Public ContactDr Parth Sarthi Jha

Tata Memorial Hospital

jukd2000@yahoo.co.uk9892358023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026